Case 10-3 Essay

486 Words2 Pages
Case 10-3 Restructuring Costs According to IAS 37, on December 27, 2008 Pharma Co. will recognize the provision for liability of $2 million dollars for the restructuring costs. On this date the plan for restructuring is communicated to employees and it meets the requirements of Paragraph 14 of IAS 37 to recognize the provision. Also, the lease termination fee of $1.3 million dollars is a provision that needs to be recognized on December 15, 2008. Paragraph 5(c) and 14 specifies the requirements to recognize the operational lease that has become onerous as a provision. This contract has become onerous on December 15 because In the Press Release Pharma Co. presents a good estimate of the cost that exceeds the benefit of the contract. IAS 73, Paragraph 73, mentions dismantling as a restructuring activity, thus the dismantling cost of 1 million dollars should be included with the provisions on December 31, 2008 Balance Sheet. However, the costs of Relocation and staff training are not included as a liability according to paragraph 81. Each cost should be recognized in its own class, they could not be aggregated because their nature is different, as per paragraph 87. There are differences in reporting the restructuring costs according to ASC 420-10. First, the liability for the termination of employees of 2 million dollars is treated the same as in IFRS. The interoffice Memorandum from December 27, 2008 constitutes the communication date to all Pharma Co. employees. The workforce reduction is expected to be completed by January 31, 2009, in within 60 days; therefore no significant present value calculation is necessary. The liability is recognized on December 27, 2008. The Press Release specifies the termination date of the contract for the lease to be January 31, 2009, the date when Pharma Co. will vacate the facility and will sign the lease

More about Case 10-3 Essay

Open Document